Short Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Rises By 6.1%

Heart Test Laboratories, Inc. (NASDAQ:HSCS) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 31,200 shares, a growth of 6.1% from the December 15th total of 29,400 shares. Currently, 3.8% of the company’s stock are sold short. Based on an average daily volume of 42,900 shares, the days-to-cover ratio is currently 0.7 days.

Heart Test Laboratories Stock Up 4.2 %

HSCS stock traded up $0.14 on Friday, reaching $3.47. 10,113 shares of the company traded hands, compared to its average volume of 53,127. The firm has a fifty day simple moving average of $3.42 and a 200-day simple moving average of $3.52. The company has a market cap of $3.40 million, a P/E ratio of -0.44 and a beta of 2.90. Heart Test Laboratories has a one year low of $2.36 and a one year high of $18.50. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.52.

Heart Test Laboratories (NASDAQ:HSCS) last posted its quarterly earnings results on Monday, December 16th. The company reported ($2.27) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.30) by $0.03. During the same period in the previous year, the business posted ($15.92) earnings per share. Research analysts anticipate that Heart Test Laboratories will post -9.82 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on HSCS. Ascendiant Capital Markets reiterated a “buy” rating and issued a $15.00 price objective on shares of Heart Test Laboratories in a report on Monday, September 23rd. Maxim Group reiterated a “buy” rating and issued a $12.00 price target on shares of Heart Test Laboratories in a research note on Wednesday, December 18th.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.